8-K Announcements
6Material company update
Feb 23, 2026·SEC
Material company update
Jan 12, 2026·SEC
Material company update
Nov 10, 2025·SEC
SI-BONE, Inc.(SIBN)Earnings, Financials & Key Ratios
SIBN•NASDAQ
$12.99
$567M mkt cap·Price updated May 6, 2026
AboutSI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers iFuse, a minimally invasive surgical implant system to address sacroiliac joint dysfunction and degeneration, adult deformity, and pelvic ring traumatic fractures. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; and iFuse-TORQ, a set of 3D-printed threaded implants designed to treat fractures of the pelvis and for minimally invasive sacroiliac joint fusion. It markets its products primarily with a direct sales force, as well as through distributors. The company was incorporated in 2008 and is headquartered in Santa Clara, California.Show more
- Revenue$201M+20.2%
- EBITDA-$20M+36.5%
- Net Income-$19M+38.8%
- EPS (Diluted)-0.44+41.3%
- Gross Margin79.57%+0.7%
- EBITDA Margin-9.76%+47.1%
- Operating Margin-11.11%+47.3%
- Net Margin-9.41%+49.1%
- ROE-10.98%+40.3%
- ROIC-10.95%+28.6%
- Debt/Equity0.01-97.2%
- Interest Coverage-4.23+58.7%
SIBN Key Insights
SI-BONE, Inc. (SIBN) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Company is almost debt free
- ✓Strong 5Y sales CAGR of 22.3%
✗Weaknesses
- ✗Negative free cash flow
- ✗Weak momentum: RS Rating 20 (bottom 20%)
- ✗Low quality earnings: Net income not backed by cash flow
- ✗Trading more than 30% below 52-week high
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
SIBN Price & Volume
SI-BONE, Inc. (SIBN) stock price & volume — 10-year historical chart
Loading chart...
SIBN Growth Metrics
SI-BONE, Inc. (SIBN) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years17.18%
5 Years22.32%
3 Years23.6%
TTM20.19%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM38.83%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM42.11%
Return on Capital
10 Years-31.99%
5 Years-24.13%
3 Years-18.41%
Last Year-10.72%
SIBN Recent Earnings
SI-BONE, Inc. (SIBN) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 12/12 qtrs (100%)●Beat Revenue 9/12 qtrs (75%)
Q1 2026Latest
Feb 23, 2026EPS
$0.04
Est $0.13
+69.2%
Revenue
$56M
Est $55M
+1.7%
Q4 2025
Nov 10, 2025EPS
$0.11
Est $0.16
+31.3%
Revenue
$49M
Est $56M
-13.5%
Q3 2025
Aug 4, 2025EPS
$0.14
Est $0.19
+26.3%
Revenue
$49M
Est $47M
+4.2%
Q2 2025
May 5, 2025EPS
$0.15
Est $0.24
+37.5%
Revenue
$47M
Est $47M
+1.2%
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q1 2026Latest | Feb 23, 2026 | $0.04vs $0.13+69.2% | $56Mvs $55M+1.7% |
| Q4 2025 | Nov 10, 2025 | $0.11vs $0.16+31.3% | $49Mvs $56M-13.5% |
| Q3 2025 | Aug 4, 2025 | $0.14vs $0.19+26.3% | $49Mvs $47M+4.2% |
| Q2 2025 | May 5, 2025 | $0.15vs $0.24+37.5% | $47Mvs $47M+1.2% |
Based on last 12 quarters of dataView full earnings history →
SIBN Peer Comparison
SI-BONE, Inc. (SIBN) competitors in Orthopedics, spine, and sports medicine — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 XTNT | 80.8M | 0.58 | -4.81 | 28.44% | 1.32% | 3.77% | 0.82 | |
 ATEC | 1.06B | 6.99 | -7.28 | 24.95% | -21.07% | -141.88% | 17.21 | |
 NVAX | 1.53B | 9.36 | 3.69 | 64.69% | -14.73% | |||
 GMED | 12.07B | 89.22 | 22.76 | 16.65% | 18.3% | 12.4% | 0.03 | |
 OSIS | 3.96B | 240.27 | 27.59 | 11.33% | 8.42% | 16.74% | 0.72 | |
 OFIX | 489.36M | 12.19 | -5.35 | 2.85% | -7.27% | -13.44% | 0.51 | |
 IART | 1.09B | 14.00 | -2.08 | 1.53% | -30.15% | -47.65% | 1.95 | |
 MMSI | 3.68B | 61.63 | 28.93 | 11.66% | 9.03% | 8.95% | 0.57 |
Compare SIBN vs Peers
SI-BONE, Inc. (SIBN) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
SIBN Income Statement
SI-BONE, Inc. (SIBN) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 47.98M | 55.38M | 67.3M | 73.39M | 90.15M | 106.41M | 138.89M | 167.18M | 200.93M |
| Revenue Growth % | 13.97% | 15.42% | 21.53% | 9.04% | 22.84% | 18.03% | 30.52% | 20.37% | 20.19% |
| Cost of Goods Sold | 5.11M | 4.83M | 6.79M | 8.9M | 10.43M | 15.71M | 29.47M | 35.06M | 41.05M |
| COGS % of Revenue | 10.65% | 8.73% | 10.09% | 12.13% | 11.57% | 14.76% | 21.22% | 20.97% | 20.43% |
| Gross Profit | 42.87M▲ 0% | 50.55M▲ 17.9% | 60.51M▲ 19.7% | 64.48M▲ 6.6% | 79.72M▲ 23.6% | 90.7M▲ 13.8% | 109.42M▲ 20.6% | 132.12M▲ 20.7% | 159.88M▲ 21.0% |
| Gross Margin % | 89.35% | 91.27% | 89.91% | 87.87% | 88.43% | 85.24% | 78.78% | 79.03% | 79.57% |
| Gross Profit Growth % | 16.07% | 17.9% | 19.71% | 6.57% | 23.63% | 13.77% | 20.63% | 20.75% | 21.01% |
| Operating Expenses | 60.22M | 62.51M | 96.51M | 103.05M | 131.39M | 150.31M | 156.35M | 167.37M | 182.21M |
| OpEx % of Revenue | 125.5% | 112.88% | 143.41% | 140.42% | 145.75% | 141.26% | 112.58% | 100.11% | 90.68% |
| Selling, General & Admin | 54.71M | 57.14M | 89.23M | 93.59M | 118.95M | 136.69M | 141.32M | 150.81M | 164.76M |
| SG&A % of Revenue | 114.02% | 103.17% | 132.59% | 127.53% | 131.95% | 128.45% | 101.75% | 90.21% | 82% |
| Research & Development | 5.51M | 5.38M | 7.28M | 9.46M | 12.44M | 13.63M | 15.03M | 16.56M | 17.45M |
| R&D % of Revenue | 11.49% | 9.71% | 10.82% | 12.89% | 13.8% | 12.81% | 10.82% | 9.91% | 8.68% |
| Other Operating Expenses | 340K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -17.35M▲ 0% | -11.96M▲ 31.0% | -36M▼ 200.9% | -38.57M▼ 7.1% | -51.67M▼ 34.0% | -59.61M▼ 15.4% | -46.93M▲ 21.3% | -35.25M▲ 24.9% | -22.33M▲ 36.6% |
| Operating Margin % | -36.16% | -21.61% | -53.5% | -52.55% | -57.31% | -56.02% | -33.79% | -21.08% | -11.11% |
| Operating Income Growth % | 1.22% | 31.04% | -200.9% | -7.12% | -33.97% | -15.36% | 21.27% | 24.89% | 36.65% |
| EBITDA | -16.34M | -11.24M | -35.23M | -37.44M | -49.58M | -56.16M | -41.5M | -30.87M | -19.61M |
| EBITDA Margin % | -34.05% | -20.3% | -52.35% | -51.01% | -55% | -52.77% | -29.88% | -18.46% | -9.76% |
| EBITDA Growth % | 1.15% | 31.18% | -213.34% | -6.27% | -32.45% | -13.26% | 26.09% | 25.62% | 36.47% |
| D&A (Non-Cash Add-back) | 1.01M | 722K | 774K | 1.13M | 2.09M | 3.45M | 5.43M | 4.38M | 2.72M |
| EBIT | -16.84M | -12.35M | -33.45M | -37.6M | -53.05M | -58.44M | -39.87M | -27.47M | -13.63M |
| Net Interest Income | -6.03M | -4.34M | -2.4M | -5M | -5.18M | -1.51M | 3.45M | 4.41M | 790K |
| Interest Income | 175K | 769K | 2.55M | 1.1M | 186K | 1.3M | 6.92M | 7.85M | 6.07M |
| Interest Expense | 6.2M | 5.11M | 4.95M | 6.1M | 5.37M | 2.82M | 3.46M | 3.44M | 5.28M |
| Other Income/Expense | -5.69M | -5.49M | -2.4M | -5.13M | -4.9M | -1.65M | 3.6M | 4.33M | 3.42M |
| Pretax Income | -23.04M▲ 0% | -17.45M▲ 24.2% | -38.4M▼ 120.0% | -43.7M▼ 13.8% | -56.57M▼ 29.5% | -61.26M▼ 8.3% | -43.34M▲ 29.3% | -30.91M▲ 28.7% | -18.91M▲ 38.8% |
| Pretax Margin % | -48.01% | -31.51% | -57.06% | -59.54% | -62.75% | -57.57% | -31.2% | -18.49% | -9.41% |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -23.04M▲ 0% | -17.45M▲ 24.2% | -38.4M▼ 120.0% | -43.7M▼ 13.8% | -56.57M▼ 29.5% | -61.26M▼ 8.3% | -43.34M▲ 29.3% | -30.91M▲ 28.7% | -18.91M▲ 38.8% |
| Net Margin % | -48.01% | -31.51% | -57.06% | -59.54% | -62.75% | -57.57% | -31.2% | -18.49% | -9.41% |
| Net Income Growth % | -11.9% | 24.25% | -120.04% | -13.79% | -29.46% | -8.28% | 29.25% | 28.67% | 38.83% |
| Net Income (Continuing) | -23.04M | -17.45M | -38.4M | -43.7M | -56.57M | -61.26M | -43.34M | -30.91M | -18.91M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -1.66▲ 0% | -1.10▲ 33.7% | -1.72▼ 56.4% | -1.50▲ 12.8% | -1.71▼ 14.0% | -1.79▼ 4.7% | -1.13▲ 36.9% | -0.75▲ 33.6% | -0.44▲ 41.3% |
| EPS Growth % | -24.81% | 33.73% | -56.36% | 12.79% | -14% | -4.68% | 36.87% | 33.63% | 41.33% |
| EPS (Basic) | -1.66 | -1.10 | -1.72 | -1.50 | -1.71 | -1.79 | -1.13 | -0.75 | -0.44 |
| Diluted Shares Outstanding | 13.87M | 15.9M | 24.71M | 29.06M | 33.15M | 34.2M | 38.43M | 41.47M | 43.51M |
| Basic Shares Outstanding | 13.87M | 15.9M | 24.71M | 29.06M | 33.15M | 34.2M | 38.43M | 41.47M | 43.51M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - |
SIBN Balance Sheet
SI-BONE, Inc. (SIBN) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 33.63M | 136.04M | 111.46M | 218.24M | 175.87M | 137.61M | 211.39M | 207.78M | 216.12M |
| Cash & Short-Term Investments | 22.41M | 122.22M | 91.78M | 196.43M | 146.98M | 97.29M | 166.02M | 150.04M | 147.82M |
| Cash Only | 22.41M | 25.12M | 10.44M | 53.58M | 63.42M | 20.72M | 33.27M | 34.95M | 42.24M |
| Short-Term Investments | 0 | 97.1M | 81.34M | 142.85M | 83.56M | 76.57M | 132.75M | 115.09M | 105.58M |
| Accounts Receivable | 7.42M | 8.49M | 11.72M | 13.61M | 14.25M | 20.67M | 21.95M | 27.46M | 29.91M |
| Days Sales Outstanding | 56.41 | 55.93 | 63.56 | 67.7 | 57.68 | 70.92 | 57.69 | 59.95 | 54.34 |
| Inventory | 2.55M | 3.34M | 5.45M | 5.63M | 11.5M | 17.28M | 20.25M | 27.07M | 33.9M |
| Days Inventory Outstanding | 182.29 | 252.47 | 293.08 | 230.96 | 402.45 | 401.65 | 250.83 | 281.88 | 301.42 |
| Other Current Assets | 0 | 1.99M | 0 | 0 | 0 | 2.37M | 3.17M | 3.2M | 4.48M |
| Total Non-Current Assets | 2.21M | 2.48M | 5.55M | 4.9M | 14.64M | 19.94M | 19.03M | 22.66M | 22.44M |
| Property, Plant & Equipment | 1.9M | 2.15M | 3.95M | 4.53M | 14.24M | 19.57M | 18.71M | 22.36M | 22.39M |
| Fixed Asset Turnover | 25.31x | 25.71x | 17.02x | 16.21x | 6.33x | 5.44x | 7.42x | 7.48x | 8.98x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 7.42M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 1.28M | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 269K | 325K | 315K | 374K | 400K | 375K | 325K | 300K | 55K |
| Total Assets | 35.83M▲ 0% | 138.52M▲ 286.6% | 117.01M▼ 15.5% | 223.14M▲ 90.7% | 190.51M▼ 14.6% | 157.55M▼ 17.3% | 230.43M▲ 46.3% | 230.44M▲ 0.0% | 238.56M▲ 3.5% |
| Asset Turnover | 1.34x | 0.40x | 0.58x | 0.33x | 0.47x | 0.68x | 0.60x | 0.73x | 0.84x |
| Asset Growth % | -9.13% | 286.56% | -15.53% | 90.7% | -14.63% | -17.3% | 46.25% | 0.01% | 3.52% |
| Total Current Liabilities | 7.54M | 9.01M | 18.77M | 13.47M | 16.89M | 21.18M | 23.46M | 27.13M | 25.28M |
| Accounts Payable | 1.81M | 2.15M | 2.81M | 3.27M | 3.2M | 6.28M | 4.59M | 6.49M | 4.63M |
| Days Payables Outstanding | 129.52 | 162.07 | 151.11 | 134.12 | 111.94 | 145.93 | 56.83 | 67.55 | 41.18 |
| Short-Term Debt | 0 | 0 | 4.36M | 0 | 0 | 0 | 0 | 0 | 944K |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 1.53M | 5.56M | 8.01M | 9.69M | 11.36M | 12.34M | 15.16M | 14.85M | 19.7M |
| Current Ratio | 4.46x | 15.11x | 5.94x | 16.20x | 10.41x | 6.50x | 9.01x | 7.66x | 8.55x |
| Quick Ratio | 4.12x | 14.73x | 5.65x | 15.78x | 9.73x | 5.68x | 8.15x | 6.66x | 7.21x |
| Cash Conversion Cycle | 109.18 | 146.33 | 205.53 | 164.54 | 348.19 | 326.64 | 251.69 | 274.28 | 314.58 |
| Total Non-Current Liabilities | 157.67M | 39.32M | 35.23M | 40.31M | 39.2M | 38.07M | 37.59M | 36.34M | 35.74M |
| Long-Term Debt | 38.7M | 38.96M | 34.87M | 39.45M | 34.97M | 35.17M | 36.06M | 35.45M | 175K |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 4.17M | 2.87M | 1.51M | 879K | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 118.97M | 360K | 362K | 854K | 57K | 30K | 18K | 10K | 35.57M |
| Total Liabilities | 165.21M | 48.33M | 54M | 53.78M | 56.09M | 59.25M | 61.05M | 63.47M | 61.02M |
| Total Debt | 38.7M | 38.96M | 39.22M | 39.45M | 40.48M | 39.43M | 38.99M | 37.48M | 1.12M |
| Net Debt | 16.3M | 13.84M | 28.79M | -14.13M | -22.94M | 18.71M | 5.72M | 2.54M | -41.12M |
| Debt / Equity | - | 0.43x | 0.62x | 0.23x | 0.30x | 0.40x | 0.23x | 0.22x | 0.01x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -2.80x | -2.34x | -7.27x | -6.32x | -9.63x | -21.15x | -13.56x | -10.25x | -4.23x |
| Total Equity | -129.38M▲ 0% | 90.19M▲ 169.7% | 63.01M▼ 30.1% | 169.36M▲ 168.8% | 134.42M▼ 20.6% | 98.3M▼ 26.9% | 169.38M▲ 72.3% | 166.96M▼ 1.4% | 177.53M▲ 6.3% |
| Equity Growth % | -18.99% | 169.71% | -30.14% | 168.8% | -20.63% | -26.87% | 72.3% | -1.42% | 6.33% |
| Book Value per Share | -9.33 | 5.67 | 2.55 | 5.83 | 4.06 | 2.87 | 4.41 | 4.03 | 4.08 |
| Total Shareholders' Equity | -129.38M | 90.19M | 63.01M | 169.36M | 134.42M | 98.3M | 169.38M | 166.96M | 177.53M |
| Common Stock | 1K | 3K | 3K | 3K | 3K | 3K | 4K | 4K | 626.97M |
| Retained Earnings | -139.72M | -157.18M | -195.58M | -239.28M | -295.85M | -357.11M | -400.44M | -431.35M | -450.26M |
| Treasury Stock | -9.94M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 402K | 439K | 464K | 524K | 352K | 232K | 335K | 244K | 816K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SIBN Cash Flow Statement
SI-BONE, Inc. (SIBN) cash flow — operating, investing & free cash flow history
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -17.53M | -14.52M | -31.63M | -30.66M | -39.53M | -41.66M | -18.71M | -12.43M | -675K |
| Operating CF Margin % | -36.53% | -26.22% | -46.99% | -41.78% | -43.85% | -39.15% | -13.47% | -7.43% | -0.34% |
| Operating CF Growth % | -4.64% | 17.18% | -117.83% | 3.05% | -28.93% | -5.37% | 55.08% | 33.6% | 94.57% |
| Net Income | -23.04M | -17.45M | -38.4M | -43.7M | -56.57M | -61.26M | -43.34M | -30.91M | -18.9M |
| Depreciation & Amortization | 1.01M | 722K | 774K | 1.13M | 2.09M | 3.45M | 5.43M | 4.38M | 2.72M |
| Stock-Based Compensation | 1.44M | 2.31M | 7.46M | 11.93M | 16.87M | 23.06M | 24.06M | 25.87M | 25.52M |
| Deferred Taxes | 1.95M | 664K | 0 | 0 | 3.56M | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 722K | 259K | -983K | 2.5M | 288K | 730K | -29K | -1.64M | -10.01M |
| Working Capital Changes | 382K | -1.02M | -479K | -2.53M | -5.76M | -7.64M | -4.83M | -10.12M | 0 |
| Change in Receivables | -1.31M | -1.02M | -3.24M | -2.19M | -569K | -6.48M | -2.12M | -5.84M | -3.03M |
| Change in Inventory | -980K | -759K | -2.1M | -274K | -5.78M | -5.71M | -4.72M | -8.05M | 2M |
| Change in Payables | 811K | 251K | 383K | 835K | -532K | 2.53M | -1.12M | 1.86M | -1.76M |
| Cash from Investing | -478K | -97.83M | 13.49M | -62.92M | 51.58M | -2.81M | -59.8M | 12.62M | 4.16M |
| Capital Expenditures | -478K | -942K | -2.44M | -2.56M | -6.39M | -9.51M | -7.8M | -10.5M | -8.41M |
| CapEx % of Revenue | 1% | 1.7% | 3.63% | 3.49% | 7.09% | 8.93% | 5.62% | 6.28% | 4.19% |
| Acquisitions | 0 | 0 | 0 | 0 | -57.97M | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | -96.88M | 0 | 0 | 57.97M | 0 | 0 | 0 | 0 |
| Cash from Financing | 12.86M | 115.15M | 3.49M | 136.4M | -1.71M | 2.2M | 90.93M | 1.96M | 3.38M |
| Debt Issued (Net) | 13.69M | 0 | 0 | -750K | -6.62M | 0 | 725K | 0 | 0 |
| Equity Issued (Net) | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | -73K | 0 | 0 | 0 | 0 | 0 | 0 | 2.21M |
| Other Financing | -6.25M | -356K | -38K | -843K | 0 | 0 | 6.54M | 1.96M | 3.38M |
| Net Change in Cash | -5.49M▲ 0% | 2.71M▲ 149.4% | -14.69M▼ 641.5% | 43.15M▲ 393.8% | 9.84M▼ 77.2% | -42.7M▼ 534.1% | 12.55M▲ 129.4% | 1.68M▼ 86.6% | 7.29M▲ 334.8% |
| Free Cash Flow | -18.01M▲ 0% | -15.46M▲ 14.1% | -34.07M▼ 120.4% | -33.22M▲ 2.5% | -45.92M▼ 38.2% | -51.16M▼ 11.4% | -26.51M▲ 48.2% | -22.92M▲ 13.5% | -9.09M▲ 60.3% |
| FCF Margin % | -37.53% | -27.92% | -50.63% | -45.27% | -50.94% | -48.08% | -19.09% | -13.71% | -4.52% |
| FCF Growth % | -4.73% | 14.14% | -120.37% | 2.49% | -38.22% | -11.41% | 48.18% | 13.54% | 60.35% |
| FCF per Share | -1.30 | -0.97 | -1.38 | -1.14 | -1.39 | -1.50 | -0.69 | -0.55 | -0.21 |
| FCF Conversion (FCF/Net Income) | 0.76x | 0.83x | 0.82x | 0.70x | 0.70x | 0.68x | 0.43x | 0.40x | 0.04x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.35M | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SIBN Key Ratios
SI-BONE, Inc. (SIBN) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | - | - | -19.35% | -50.13% | -37.61% | -37.24% | -52.64% | -32.38% | -18.38% | -10.98% |
| Return on Invested Capital (ROIC) | - | - | - | -27.58% | -23.42% | -29.06% | -39.13% | -24.1% | -15.34% | -10.95% |
| Gross Margin | 87.73% | 89.35% | 91.27% | 89.91% | 87.87% | 88.43% | 85.24% | 78.78% | 79.03% | 79.57% |
| Net Margin | -48.9% | -48.01% | -31.51% | -57.06% | -59.54% | -62.75% | -57.57% | -31.2% | -18.49% | -9.41% |
| Debt / Equity | - | - | 0.43x | 0.62x | 0.23x | 0.30x | 0.40x | 0.23x | 0.22x | 0.01x |
| Interest Coverage | -5.31x | -2.80x | -2.34x | -7.27x | -6.32x | -9.63x | -21.15x | -13.56x | -10.25x | -4.23x |
| FCF Conversion | 0.81x | 0.76x | 0.83x | 0.82x | 0.70x | 0.70x | 0.68x | 0.43x | 0.40x | 0.04x |
| Revenue Growth | 2.25% | 13.97% | 15.42% | 21.53% | 9.04% | 22.84% | 18.03% | 30.52% | 20.37% | 20.19% |
SIBN SEC Filings & Documents
SI-BONE, Inc. (SIBN) SEC filings — annual & quarterly reports (10-K, 10-Q)
SIBN Frequently Asked Questions
SI-BONE, Inc. (SIBN) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
SI-BONE, Inc. (SIBN) reported $200.9M in revenue for fiscal year 2025. This represents a 310% increase from $49.0M in 2013.
SI-BONE, Inc. (SIBN) grew revenue by 20.2% over the past year. This is strong growth.
SI-BONE, Inc. (SIBN) reported a net loss of $18.9M for fiscal year 2025.
Dividend & Returns
SI-BONE, Inc. (SIBN) has a return on equity (ROE) of -11.0%. Negative ROE indicates the company is unprofitable.
SI-BONE, Inc. (SIBN) had negative free cash flow of $9.1M in fiscal year 2025, likely due to heavy capital investments.
Explore More SIBN
SI-BONE, Inc. (SIBN) financial analysis — history, returns, DCA and operating performance tools
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates